MIRA Pharmaceuticals (MIRA) News Today $1.05 -0.05 (-4.55%) (As of 12/29/2023 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMira Pharmaceuticals (MIRA) Earnings Dates & Reportsinvesting.com - December 20 at 1:13 AMMIRA Pharmaceuticals files to sell up to 1.7M shares for holdersmsn.com - December 18 at 7:48 PMIPO Update: Telomir Pharmaceuticals Proposes IPO Termsseekingalpha.com - December 16 at 2:45 PMMIRA Pharma: AI Simulation On MIRA1a Shows Advantages Over Plant-Based Medical Marijuanamarkets.businessinsider.com - December 4 at 9:20 AMMIRA Pharmaceuticals Releases Breakthrough Data from Artificial Intelligence Simulationsfinance.yahoo.com - December 4 at 9:20 AMmarketbeat.com - December 1 at 1:02 PMMIRA Pharmaceuticals Announces Ketamir-2's Oral Bioavailability Predicted to be 80%finance.yahoo.com - November 29 at 10:15 AMMIRA Makes Great Deal for Potential Blockbusterfinance.yahoo.com - November 27 at 4:35 PMAQB, BIVI and SHOT among mi-day moversseekingalpha.com - November 22 at 9:45 PMMira Pharmaceuticals Incmorningstar.com - November 22 at 6:43 AMMira Pharmaceuticals Inc MIRAmorningstar.com - November 21 at 10:17 PMMIRA Pharmaceuticals Announces Paradigm-Shift in Cognitive Enhancement with MIRA1afinance.yahoo.com - November 21 at 12:15 PMMIRA Pharmaceuticals To Host Shareholder Update Call on Tuesday, December 5, 2023 at 11:30 a.m. Eastern Timefinance.yahoo.com - November 21 at 12:15 PMMIRA Pharma Partners With MIRALOGX For Licensing Agreement For Ketamir-2markets.businessinsider.com - November 20 at 3:39 PMShares of MIRA Pharmaceutical Soar 92% on Licensing Agreement for Ketamine Treatmentmarketwatch.com - November 20 at 3:39 PMWhy Is Depression Focused MIRA Pharmaceuticals Stock Trading Higher Today?msn.com - November 20 at 3:39 PMmarketbeat.com - November 20 at 10:53 AMmarketbeat.com - November 20 at 10:33 AMmarketbeat.com - November 20 at 10:33 AMmarketbeat.com - November 20 at 10:14 AMOpenAI appoints former Twitch boss Emmett Shear CEO after shock departure of Sam Altmannz.finance.yahoo.com - November 20 at 8:21 AMMIRA Pharmaceuticals Shows its Prescription Pill More Palatable and Potent Than Potfinance.yahoo.com - November 20 at 8:21 AMMIRA: Developing Cannabis with Benefits and Without Side Effectsfinance.yahoo.com - November 20 at 8:21 AMMIRA Continues to Pursue New Pain Relieffinance.yahoo.com - November 20 at 8:21 AMMIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2finance.yahoo.com - November 20 at 8:21 AMmarketbeat.com - September 18 at 11:49 AMmarketbeat.com - September 18 at 11:30 AMmarketbeat.com - September 13 at 9:35 AMGeorge Cappy Mira Pharmaceuticals, Incbenzinga.com - August 25 at 4:50 PMMIRA Pharmaceuticals debuts on the Nasdaq with plans to revolutionize medicinal CBD and THCfinance.yahoo.com - August 14 at 8:29 AMMIRA Pharmaceuticals, Inc. Discusses Potential of Revolutionary THC Analog Drug, MIRA1a, with The Stock Day Podcastfinance.yahoo.com - August 14 at 8:29 AM Get MIRA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRA and its competitors with MarketBeat's FREE daily newsletter. Email Address MIRA Media Mentions By Week MIRA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MIRA News Sentiment▼-1.140.84▲Average Medical News Sentiment MIRA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MIRA Articles This Week▼82▲MIRA Articles Average Week Get MIRA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sensei Biotherapeutics News Today Aytu BioPharma News Today CalciMedica News Today Bullfrog AI News Today NeuroBo Pharmaceuticals News Today TFF Pharmaceuticals News Today Lipocine News Today NuCana News Today Akari Therapeutics News Today DURECT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:MIRA) was last updated on 12/31/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.